Patient Selection, Pretransplant Management, Donor and Recipient Matching

The prevalence of advanced heart failure (HF) is on the rise and patients today are older, more complex and at higher risk of poor outcomes. Despite advances in evidence-based therapies, or in some instances a result of, there is often progression towards end stage HF. Timely referral to advanced HF specialists is imperative to improve quality of life, and in select patients, prolong life expectancy.